Translational News in the Obesity Week: Advancing the metabolic fatty liver disease agenda

From Friday, September 11, 2020 to Friday, September 11, 2020

Apertura:

Gema Medina Universidad Rey Juan Carlos. SEEDO
Manuel Tena-Sempere. Universidad de Córdoba.CIBEROBN

Presentaciones:

Metabolic determinants of NAFLD transition to NASH. Toni Vidal-Puig (TVP Lab, WT/MRC Institute of Metabolic Science, MRC Metabolic Diseases Unit - Metabolic Research Laboratories, University of Cambridge, Cambridge, UK)

The mitochondrial protein Mitofusin 2 and liver damage . Antonio Zorzano (CIBERDEM, Institute for Research in Biomedicine (IRB Barcelona), Departament de Bioquímica i Biomedicina Molecular, Universitat de Barcelona)